Back to Journals » Breast Cancer: Targets and Therapy » Volume 10

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

Total article views   Abstract views HTML views PDF downloads Totals
5,671 Dovepress* 4,644 602+ 825 5,246
PubMed Central* 0 425 98 425
Totals 4,644 1,027 923 5,671
*Since 22 March 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
40 1 0 0 7 32

View citations on PubMed Central and Google Scholar